Neoadjuvant Modified FOLFIRINOX in Borderline Resectable Pancreatic Cancer
Clinical trial NCT02749136 · COMPLETED
Trial details
- NCT number
- NCT02749136
- Sponsor
- Asan Medical Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-01
- Primary completion
- 2019-09-01
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.